Yu Okubo

Yu Okubo

Auto-generated profile, based on publicly available information

Yu Okubo

Division of Thoracic Surgery, Department of Surgery Keio University School of Medicine Tokyo Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
YOYu Okubo
Yu Okubo
YYYukihiro Yoshida
Yukihiro Yoshida
MYMasaya Yotsukura
Masaya Yotsukura
KNKazuo Nakagawa
Kazuo Nakagawa
SWShun-Ichi Watanabe
Shun-Ichi Watanabe
Segmentectomies can be classified as simple or complex and are increasingly performed for early-stage lung cancer. Complex segmentectomy requires the creation of multiple intersegmental planes and is considered a more arduous procedure with higher risks of postoperative complications, relative to simple segmentectomy. This retrospective study evaluated patients who underwent simple or complex segmentectomy for primary lung cancer during 2012–2018. Perioperative factors were compared according to the procedure type. The 538 eligible segmentectomies included 251 complex segmentectomies and 287 simple segmentectomies. There were no significant differences in terms of age, sex, smoking history or comorbidities. The most common procedure in the complex segmentectomy group was upper-lobe segmentectomy (e.g. S1, S2, S3 and S1 + 2; n = 170), which was followed by S8 segmentectomy (n = 39) and two-segment segmentectomies (e.g. S7 + 8, S8 + 9 and S9 + 10; n = 24). Simple segmentectomies involved left upper division (n = 117), the lingular segment (n = 30) and the S6 segment (n = 140). Comparing complex and simple segmentectomies revealed equivalent median operative times (113 vs 113 min) and blood loss (20 vs 20 ml). Complex segmentectomy had fewer postoperative complications (2.0% vs 7.0%, P = 0.006), including prolonged air leak (0.8% vs 3.5%, P = 0.035) and shorter median postoperative stays (3 vs 4 days, P < 0.001). However, median surgical margins were closer for complex segmentectomy (22 vs 25 mm, P = 0.005) The perioperative outcomes of complex segmentectomy were satisfactory and comparable to those of simple segmentectomy. Surgeons should pay careful attention to the surgical margins during complex segmentectomy.

27 August 2025 in Lung Cancer
Verified
Journal Article
Open access
SOSeiji Omura
Seiji Omura
YKYutaka Kurebayashi
Yutaka Kurebayashi
JHJunko Hamamoto
Junko Hamamoto
HTHideki Terai
Hideki Terai
TITomohiro Imoto
Tomohiro Imoto
KAKeisuke Asakura
Keisuke Asakura
Thymic neuroendocrine tumors (TNETs) are rare malignancies characterized by aggressive clinical behavior and limited therapeutic options. In small cell lung cancer (SCLC), molecular subtypes based on the expression of lineage-defining transcription factors (TFs)-ASCL1, NEUROD1, POU2F3, and YAP1-have been proposed. However, the TF landscape of TNETs remains poorly defined. Given the pathological similarities among neuroendocrine tumors across organs, we aimed to investigate whether the TF-based classification system used in SCLC is applicable to TNETs. Sixteen pathologically confirmed TNETs-including large cell neuroendocrine carcinoma (LCNEC), thymic small cell carcinoma (TSCC), atypical carcinoid (AC), and typical carcinoid (TC)-were retrospectively analyzed. Immunohistochemistry was performed to evaluate classical neuroendocrine (NE) markers (synaptophysin, chromogranin A, CD56) and TFs (ASCL1, NEUROD1, POU2F3, YAP1). H-scores were calculated, and tumors were categorized according to TFs expression profiles. Synaptophysin was strongly expressed in all cases, while chromogranin A and CD56 showed variable expression, with reduced levels in LCNEC and TSCC. The combined NE score was significantly higher in carcinoid tumors compared to LCNEC and TSCC. For TFs, ASCL1 expression was observed in 93.8 % of cases, whereas NEUROD1 and POU2F3 were rarely or not expressed. YAP1 expression was confined to LCNEC cases, all of which co-expressed ASCL1 and YAP1. Based on H-scores, TNETs were classified into three subgroups: (1) ASCL1-positive/YAP1-negative (n = 12, 75 %), (2) ASCL1/YAP1 double-positive (n = 3, 19 %), and (3) double-negative (n = 1, 6 %). This study reveals molecular heterogeneity among TNETs. Notably, ASCL1 and YAP1 co-expression characterizes all LCNEC cases, making a distinct TF landscape in high-grade TNETs.

19 December 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
PDF file
NKNaonori Kawakubo
Naonori Kawakubo
YOYu Okubo
Yu Okubo
MYMasaya Yotsukura
Masaya Yotsukura
YYYukihiro Yoshida
Yukihiro Yoshida
KNKazuo Nakagawa
Kazuo Nakagawa
SWShun-Ichi Watanabe
Shun-Ichi Watanabe

25 August 2025 in Lung Cancer
Verified
Journal Article
Open access
ATAkiko Tateishi
Akiko Tateishi
HHHidehito Horinouchi
Hidehito Horinouchi
NKNobuji Kouno
Nobuji Kouno
KTKatsuji Takeda
Katsuji Takeda
KTKen Takasawa
Ken Takasawa
RHRyuji Hamamoto
Ryuji Hamamoto
Integrated recurrence prediction models that combine clinical, imaging, and genetic data are lacking for epidermal growth factor receptor (EGFR)-mutated stage I non-small cell lung cancer (NSCLC). We developed a recurrence prediction model for Stage I EGFR-mutated NSCLC by integrating clinical, radiological, and whole-exome sequencing (WES) data. A total of 306 patients with Stage I EGFR-mutated NSCLC were stratified into training (n = 206) and validation (n = 100) cohorts using stratified random sampling. Cox proportional hazards models combined binary labels of clinical and radiological factors from univariate analysis, machine-learning-derived MultiGenes labels (determined by multiple gene mutations) from WES data, and high-impact gene mutations. Predictive performance was assessed using the concordance index (C-index), time-dependent area under the curve (AUC), and receiver operating characteristic curves. The top three models by category were evaluated using a survival analysis. Three optimal models were identified; the clinicoradiological model (Model 17) achieved a C-index of 0.70, the model incorporating clinicoradiological factors and MultiGenes (Model 28) achieved 0.69, and the clinicoradiological model with TP53 mutations (Model 39) demonstrated the best performance, with 0.73. In Model 17, the 60-month recurrence-free survival (RFS) rates were 59.1 % for the high-risk group and 83.2 % for the low-risk group (hazard ratio [HR] = 3.47; 95 % confidence interval [CI]: 1.60-8.00). Model 39, which incorporated TP53 mutations, demonstrated superior performance, with 60-month RFS rates of 57.1 % for the high-risk and 87.1 % for the low-risk groups (HR = 4.79; 95 %CI: 1.96-11.69). Clinical and radiological factors are effective predictors of recurrence risk in Stage I EGFR-mutated NSCLC, and incorporating TP53 mutation data further improves the prognostic accuracy.

16 February 2024 in Annals of Thoracic Surgery Short Reports
Verified
Journal Article
Open access
KYKaito Yano
Kaito Yano
YOYu Okubo
Yu Okubo
YIYuki Ishiguro
Yuki Ishiguro
KMKyohei Masai
Kyohei Masai
KKKaoru Kaseda
Kaoru Kaseda
KAKeisuke Asakura
Keisuke Asakura
A pheochromocytoma is a malignant tumor with metastatic potential. Moreover, the cardiovascular effects of abnormal amounts of catecholamines resulting from pheochromocytoma impact prognosis. Resection of the primary tumor is useful for reducing catecholamine production; however, the significance of resection of metastases remains unclear. Herein, we report a case in which multiple lung resections for metastases from pheochromocytoma were performed 5 years after primary tumor resection. Complete resection of 6 pulmonary lesions was achieved, maintaining reduced catecholamine levels and blood pressure without any sign of recurrence for a year.

3 November 2023 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
NONaoyuki Oka
Naoyuki Oka
KMKyohei Masai
Kyohei Masai
YOYu Okubo
Yu Okubo
KKKaoru Kaseda
Kaoru Kaseda
THTomoyuki Hishida
Tomoyuki Hishida
AKAsakura Keisuke
Asakura Keisuke
Pectus excavatum (PE) is often associated with scoliosis and can elicit cardiovascular disturbances under rare conditions. Here we report a patient who was treated with a combined Ravitch and Nuss procedure for PE with dyspnea following scoliosis repair to improve her symptoms. The patient was a 49-year-old woman with a history of PE and scoliosis. Right inferior pulmonary vein stenosis was caused by posterior spinal fusion for scoliosis prior to the PE repair. We could safely correct the chest wall deformity and treat dyspnea by performing a modified Ravitch repair in combination with the Nuss procedure.